OPK
USDOPKO Health Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.370
Kõrge
$1.430
Madal
$1.370
Maht
2.69M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.1B
Tööstusharu
Diagnostics & Research
Riik
United States
Kauplemisstatistika
Keskmine maht
2.21M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Jefferies Downgrades OPKO Health to Hold, Lowers Price Target to $1.6
Jefferies analyst Maury Raycroft downgrades OPKO Health from Buy to Hold and lowers the price target from $2 to $1.6.
Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target
Barrington Research analyst Michael Petusky maintains OPKO Health with a Outperform and maintains $2.25 price target.
OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) --
OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28,
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.